Product Information
RGAM004 targets Mouse IgG (H+L) in FC and IF. It can bind to all mouse IgG isotypes, mouse IgM and IgA as well as rat IgG. It shows minimal reactivity for rabbit, human, pig and bovine IgGs.
| Concentration | 0.5 mg/mL | 
| Applications | IF, FC | 
| Host Species | Goat | 
| Species Reactivity | Mouse | 
| Physical State | Liquid | 
| Suggested Dilution Range | 1:200-1:1000 for IF and FC | 
| Purity | The antibody was purified from culture media supernatant by immunoaffinity chromatography using Protein G beads. | 
| Storage Buffer | PBS with 50% glycerol, 10 mg/mL BSA, 0.1% Proclin-300, pH 7.4. | 
| Storage Instructions | Store at -20°C. Stable for one year after shipment. | 
| Fluorophore | CoraLite® Plus 594, Amax=588 nm, Emax=604 nm | 
| Clonality | Multiclonal recombinant | 
| RRID | AB_3073502 | 
| Note | This product is for research use only,not for diagnostic or therapeutic use. | 
Background
Publications
| Title | 
|---|
| Biochem Pharmacol Discovery of a novel microtubule destabilizing agent targeting the colchicine site based on molecular docking | 
| bioRxiv Comparative analysis of the syncytiotrophoblast in placenta tissue and trophoblast organoids using snRNA sequencing | 
| Stem Cells Int Astragaloside IV Treats Parkinson's Disease by Regulating the Proliferation and Differentiation of NSCs through the SHH-Nurr1 Pathway | 
| Mol Neurobiol Oxidative Stress-mediated Loss of Hippocampal Parvalbumin Interneurons Contributes to Memory Precision Decline After Acute Sleep Deprivation | 
| Biochem Pharmacol SMURF1 leads to the β-catenin signaling-mediated progression of esophageal squamous carcinoma by losing PATZ1-induced CCNG2 transcription | 






